Diagnosis and classification of autoimmune optic neuropathy

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 539-545

  Petzold, Axel ^a,c   Plant, Gordon T ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER;

AUTOIMMUNE DISEASE; CAUCASIAN; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NERVE DISEASE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TREATMENT RESPONSE; VISION; VISUAL ACUITY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; HUMANS; OPTIC NERVE DISEASES; PROGNOSIS; RECURRENCE;

EID: 84896314000     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.009     Document Type: Review

References (68)

1. Alter M., Good J., Okihiro M. Optic neuritis in Orientals and Caucasians. Neurology 1973, 23:631-639.
2. Beck R.W., Gal R.L., Bhatti M.T., Brodsky M.C., Buckley E.G., et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 2004, 137:77-83.
3. Bee Y.S., Lin M.C., Wang C.C., Sheu S.J. Optic neuritis: clinical analysis of 27 cases. Kaohsiung J Med Sci 2003, 19:105-112.
4. Bouyon M., Collongues N., Zéphir H., Ballonzoli L., Jeanjean L., Lebrun C., et al. Longitudinal follow-up of vision in a neuromyelitis optica cohort. Mult Scler 2013, 19:1320-1322.
5. Brettschneider J., Petzold A., Junker A., Tumani H. Axonal damage markers in cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite MS. Mult Scler 2006, 12:143-148.
6. Chang Yo-Chen, Wu Wen-Chuan, Tsai Rong-Kung Prognosis of Taiwanese patients with isolated optic neuritis after intravenous methylprednisolone pulse therapy. J Formos Med Assoc 2007, 106:656-663.
7. Collinge Janine E., Sprunger Derek T. Update in pediatric optic neuritis. Curr Opin Ophthalmol 2013, 24:448-452.
8. Costello F., Hodge W., Pan Y.I., Eggenberger E., Coupland S., Kardon R.H. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 2008, 14:893-905.
9. Costello Fiona, Coupland Stuart, Hodge William, Lorello Gianni R., Koroluk Jeannie, Irene Pan Y., et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006, 59:963-969.
10. Dinkin Marc J., Cestari Dean M., Stein Marion C., Brass Steve D., Lessell Simmons NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis. Arch Ophthalmol 2008, 126:566-570.
11. Donato Rosario, Sorci Guglielmo, Riuzzi Francesca, Arcuri Cataldo, Bianchi Roberta, Brozzi Flora, et al. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 2009, 1793:1008-1022.
12. Du Yi, Yang Jun, Li Jing-Jing, Zhou Rui-Wu, He Jian-Feng Unilateral optic neuritis in a Chinese population in three centers. J Clin Neurosci 2011, 18:902-904.
13. Fernandes Danilo B., Ramos Renata de Iracema P., Falcochio Carolina, Apóstolos-Pereira Samira, Callegaro Dagoberto, Monteiro Mário Luiz Ribeiro Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis. J Neuroophthalmol 2012, 32:102-106.
14. Fiddes Barnaby, Wason James, Kemppinen Anu, Ban Maria, Compston Alastair, Sawcer Stephen Confounding underlies the apparent month of birth effect in multiple sclerosis. Ann Neurol 2013, 73:714-720.
15. Firth D. The case of Augustus d'Este 1948, Cambridge University Press.
16. Frederiksen J., Kristensen K., Bahl J.M.C., Christiansen M. Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis. Mult Scler 2012, 18:592-599.
17. Fujii Chihiro, Tokuda Takahiko, Ishigami Noriko, Mizuno Toshiki, Nakagawa Masanori Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome. Neurosci Lett 2011, 494:86-88.
18. von Graefe A. Über Complication von Sehnervenentzündung mit Gehirnkrankheiten. Arch Ophthalmol 1860, 1:58-71.
19. Optic Neuritis Study Group Visual function 15years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology 2008, 115:1079-1082.
20. Hickman Simon J., Toosy Ahmed T., Jones Stephen J., Altmann Daniel R., Miszkiel Katharine A., MacManus David G., et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004, 127:2498-2505.
21. Hickman S.J., Dalton C.M., Miller D.H., Plant G.T. Management of acute optic neuritis. Lancet 2002, 360:1953-1962.
22. Jain I.S., Munjal V.P., Dhir S.P., Gangwar D.N. Profile of optic neuritis in Chandigarh and surrounding areas. Indian J Ophthalmol 1981, 28:195-200.
23. Jarius Sven, Ruprecht Klemens, Wildemann Brigitte, Kuempfel Tania, Ringelstein Marius, Geis Christian, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 2012, 9:14.
24. Jellinek E.H. Heine's illness: the case for multiple sclerosis. J R Soc Med 1990, 83:516-519.
25. Jin Y., de Pedro-Cuesta J., Söderström M., Stawiarz L., Link H. Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 2000, 181:56-64.
26. Kinoshita Makoto, Nakatsuji Yuji, Moriya Masayuki, Okuno Tatsusada, Kumanogoh Atsushi, Nakano Misa, et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport 2009, 20:508-512.
27. Joanna Kitley M., Leite Isabel, Nakashima Ichiro, Waters Patrick, McNeillis Benjamin, Brown Rachel, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 2012, 135:1834-1849.
28. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
29. Lim S.A., Goh K.Y., Tow S., Fu E., Wong T.Y., Seah A., et al. Optic neuritis in Singapore. Singapore Med J 2008, 49:667-671.
30. Matiello M., Lennon V.A., Jacob A., Pittock S.J., Lucchinetti C.F., Wingerchuk D.M., et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008, 70:2197-2200.
31. Matiello Marcelo, Schaefer-Klein Janet, Sun David, Weinshenker Brian G. Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica. JAMA Neurol 2013, 70:1118-1125.
32. Medaer R. Does the history of multiple sclerosis go back as far as the 14th century?. Acta Neurol Scand 1979, 60:189-192.
33. Misu T., Takano R., Fujihara K., Takahashi T., Sato S., Itoyama Y. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 2009, 80:575-577.
34. Nettleship E. On cases of retro-ocular neuritis. Trans Ophthalmol Soc U K 1884, 4:186-226.
35. Petzold A., Eikelenboom M.J., Gveric D., Keir G., Chapman M., Lazeron R.H.C., et al. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 2002, 125:1462-1473.
36. Petzold A., Marignier R., Verbeek M.M., Confavreux C. Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases. J Neurol Neurosurg Psychiatry 2011, 82:467-469.
37. Petzold A., Pittock S., Lennon V., Gale R., Wanijha A., Caulkin R., et al. Chronic relapsing inflammatory optic neuropathy (CRION): an extension of the NMO spectrum disorder. J Neurol Neurosurg Psychiatry 2008, 352. [Presentation at the Association of British Neurologists (ABN)].
38. Petzold A., Pittock S., Lennon V., Maggiore C., Weinshenker B.G., Plant G.T. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 2010, 81:109-111.
39. Petzold A., Rejdak K., Plant G.T. Axonal degeneration and inflammation in acute optic neuritis. J Neurol Neurosurg Psychiatry 2004, 75:1178-1180.
40. Petzold Axel, de Boer Johannes F., Schippling Sven, Vermersch Patrik, Kardon Randy, Green Ari, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010, 9:921-932.
41. Petzold Axel, Plant Gordon T. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 2013, [epub ahead of print].
42. Petzold Axel, Plant Gordon T. The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies. Mult Scler Int 2012, 2012:217802.
43. Pirko I., Blauwet L.K., Lesnick T.G., Weinshenker B.G. The natural history of recurrent optic neuritis. Arch Neurol 2004, 61:1401-1405.
44. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 2005, 58:840-846.
45. Robinson-Agramonte Maria A., Saravia Gonçalves Carlos Alberto, Portela L.Valmor, Portela Valmor L., Saiz-Hinarejos A., Oses Jean Pierre, et al. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica. Neuroimmunomodulation 2010, 17:177-179.
46. Sabater Lidia, Giralt Albert, Boronat Anna, Hankiewicz Karolina, Blanco Yolanda, Llufriu Sara, et al. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J Neuroimmunol 2009, 215:31-35.
47. Shatriah I., Wan Hitam W.H., Nor-Idahriani M.N., Daud J., Zunaina E. Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia-5years review. Med J Malaysia 2012, 67:159-164.
48. Shatriah Ismail, Adlina Abdul-Rahim, Alshaarawi Salem, Wan-Hitam Wan-Hazabbah Clinical profile of Malay children with optic neuritis. Pediatr Neurol 2012, 46:293-297.
49. Sri-udomkajorn Somjit, Pongwatcharaporn Kea Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health. J Med Assoc Thai 2011, 94(Suppl. 3):S189-S194.
50. Storoni Mithu, Davagnanam Indran, Radon Mark, Siddiqui Ata, Plant Gordon T. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol 2013, 33:123-127.
51. Storoni Mithu, Petzold Axel, Plant Gordon T. The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis. PLoS One 2011, 6:e23489.
52. Storoni Mithu, Pittock Sean J., Weinshenker Brian G., Plant Gordon T. Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage. J Neurol Sci 2012, 312:21-25.
53. Storoni Mithu, Verbeek Marcel M., Illes Zsolt, Marignier Romain, Teunissen Charlotte E., Grabowska Magda, et al. Serum GFAP levels in optic neuropathies. J Neurol Sci 2012, 317:117-122.
54. Sun M.-H., Wang H.-S., Chen K.-J., Su W.-W., Hsueh P.-Y., Lin K.-K., et al. Clinical characteristics of optic neuritis in Taiwanese children. Eye (Lond) 2011, 25:1457-1464.
55. Takagi Mineo, Tanaka Keiko, Suzuki Tone, Miki Atsushi, Nishizawa Masatoyo, Abe Haruki Anti-aquaporin-4 antibody-positive optic neuritis. Acta Ophthalmol 2009, 87:562-566.
56. Takano R., Misu T., Takahashi T., Sato S., Fujihara K., Itoyama Y. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010, 75:208-216.
57. Talla Venu, Yang Cui, Shaw Gerry, Porciatti Vittorio, Koilkonda Rajeshwari D., Guy John Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis. Invest Ophthalmol Vis Sci 2013, 54:4440-4450.
58. Taylor Bruce V., Lucas Robyn M., Dear Keith, Kilpatrick Trevor J., Pender Michael P., van der Mei Ingrid A.F., et al. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler 2010, 16:398-405.
59. Uzawa Akiyuki, Mori Masahiro, Masuda Saeko, Muto Mayumi, Kuwabara Satoshi CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2013, 84:517-522.
60. Uzawa Akiyuki, Mori Masahiro, Sawai Setsu, Masuda Saeko, Muto Mayumi, Uchida Tomohiko, et al. Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clin Chim Acta 2013, 421:181-183.
61. Wang J.C., Tow S., Aung T., Lim S.A., Cullen J.F. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Experiment Ophthalmol 2001, 29:312-315.
62. Wang K.-C., Tsai C.-P., Lee C.-L., Chen S.-Y., Chin L.-T., Chen S.-J. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica. Neuroscience 2012, 226:510-516.
63. Waters P.J., McKeon A., Leite M.I., Rajasekharan S., Lennon V.A., Villalobos A., et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671.
64. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
65. World Health Organisation ICD-10 classifications of mental and behavioural disorder: clinical descriptions and diagnostic guidelines 1992, [Geneva].
66. World Health Organization Neurological disorders. Public health challenges 2007, World Health Organization, Geneva.
67. Yang Yang, Wu Wei-ping, Huang De-hui, Wu Lei Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system. Zhonghua Yi Xue Za Zhi 2012, 92:3032-3035.
68. Zhang Jia-ying, Shen Xu-zhong, Sun Li, Zhao-zeng Lu., Ye Wen Clinical and pathological features of acute optic neuritis in Chinese patients. Chin Med J (Engl) 2013, 126:1689-1692.